About Us

In recent decades, the number of people dying from cancer in the U.S. has declined by almost one-third – a statistic that translates into hope and relief for patients and their families. Advances in treating cancer patients with immunotherapy, improved screening, and earlier diagnosis are largely credited with this progress. Immunotherapy is now a beacon of hope for millions of patients worldwide treated with it each year, and the scientific consensus is now irrefutable: cancer immunotherapy is a modern and innovative way to treat cancer. The journal Science named immunotherapy “Scientific Breakthrough of the Year” in 2013, and immunotherapy continues to benefit more patients each year. Up to one-third of all cancer patients are now eligible for treatment with immunotherapy and have new treatment options and more hope for living longer.

We Employ Latest Research Technology & Company

Acute Medical Research Institute (A.M.R.I) established and continues to foster the field of cancer immunotherapy since its official incorporation on January 27, 1963. This year, A.M.R.I celebrated its 70th birthday and is proud to see how far the field has developed since with A.M.R.I’s unwavering support.

From the dedicated work of the thousands of scientists who have received funding from A.M.R.I since 1963, A.M.R.I has produced important discoveries that have driven progress in cancer treatment not seen since the 1940s. Although the job is not yet complete, we invite you to learn about the institutional milestones, scientific discoveries, and people involved in making A.M.R.I the primary authority in cancer immunotherapy that it is today.

400+

Complete Cases

Expert Staff